"Future investigations are warranted to disentangle the relative 
contribution of antipsychotic medications, maternal mental illness, 
concomitant (associated) medications and the broader psychosocial 
context in the developmental trajectory of high-risk infants.

Pending such studies, these data support an additional level of 
clinical scrutiny in medication selection, treatment planning and 
risk/benefit discussions for women with illnesses who may warrant 
antipsychotic pharmacotherapy during gestation."

http://www.medicalnewstoday.com/articles/243798.php



Powered by LSoft's LISTSERV(R) list management software